Severe, Active Atopic Eczema Tied to Increased Mortality Risk
WEDNESDAY, Feb. 3, 2021 -- There is an increased risk for all-cause and cause-specific mortality among patients with atopic eczema, particularly among those with the most severe or predominantly active disease, according to a study published online Jan. 27 in the Journal of Allergy and Clinical Immunology.
Richard J. Silverwood, Ph.D., from the London School of Hygiene and Tropical Medicine, and colleagues assessed whether adults with atopic eczema were at increased risk for death overall and whether the risk varied by atopic eczema severity and activity. The analysis included 526,736 patients identified through U.K. primary care electronic health care records, as well as 2,567,872 matched controls with a median follow-up of 4.5 years.
The researchers found limited evidence of an increased hazard for all-cause mortality in those with atopic eczema (hazard ratio, 1.04), owing to the low mortality rates overall, but there were somewhat stronger associations (hazard ratios, from 1.08 to 1.14) for deaths due to infectious, digestive, and genitourinary causes. There was a markedly increased mortality risk associated with eczema severity and activity. Patients with severe atopic eczema had a significantly increased risk for mortality (hazard ratio, 1.62) versus those without eczema, with the strongest associations seen for infectious, respiratory, and genitourinary causes.
"Although the absolute risk of death from severe eczema is low, our findings suggest that those with severe or more active forms of the disease do face a higher risk of dying from associated health issues," a coauthor said in a statement. "We hope that this new information will help inform further research to better understand this pattern and the underlying mechanisms of these associations, and subsequently inform and improve treatment processes for those with severe eczema."
© 2021 HealthDay. All rights reserved.
Posted: February 2021
Read this next
THURSDAY, Feb. 25, 2021 -- For women aged younger than 65 years, the mortality gap between cancer and heart disease is narrowing, according to a study published online Feb. 8 in...
THURSDAY, Feb. 25, 2021 -- Negative changes in brain volumes and cognitive scores persist over time in children with early-onset type 1 diabetes, according to a study published...
THURSDAY, Feb. 25, 2021 -- There is underrepresentation of racial/ethnic minorities and older patients among U.S.-based vaccine clinical trials, while female adults are...
More News Resources
- FDA Medwatch Drug Alerts
- Daily MedNews
- News for Health Professionals
- New Drug Approvals
- New Drug Applications
- Drug Shortages
- Clinical Trial Results
- Generic Drug Approvals
Subscribe to our Newsletter
Whatever your topic of interest, subscribe to our newsletters to get the best of Drugs.com in your inbox.